SEC Form 4 · accession 0001140361-16-090255
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Root
Officer — Chief Executive Officer · Director
Period of report
Dec 15, 2016
Accepted (ET)
Dec 19, 2016 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 15, 2016 | G | 4,000 | $0.00 | D | 341,840 | D | |
| Common Stock | Dec 16, 2016 | G | 1,000 | $0.00 | D | 340,840 | D | |
| Common Stock | holding | — | — | — | 345,840 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | — | holding | — | — | — | — | Jan 27, 2022 | Common Stock | 360,000 | 360,000 | D |
Explanation of responses
- F190,000 shares vested on January 27, 2014 with an exercise price of $12.03/share. 90,000 shares vested on January 27, 2015 with an exercise price of $13.03/share. 90,000 shares vested on January 27, 2016 with an exercise price of $14.03/share. 90,000 shares vest on January 27, 2017 with an exercise price of $15.03/share.